Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hoffmann

Showing results (831-840 of 874) with videos related to

Pageof 88
Sort By:
Nature Communications|February 6, 2024
A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1Ling Hai, Dirk C Hoffmann, Robin J Wagener, et al.
Plos Medicine|March 29, 2021
The PRISMA 2020 statement: An updated guideline for reporting systematic reviewsMatthew J Page, Joanne E McKenzie, Patrick M Bossuyt, et al.
BMJ (Clinical Research Ed.)|March 30, 2021
The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsMatthew J Page, Joanne E McKenzie, Patrick M Bossuyt, et al.
Revista Espanola De Cardiologia (English Ed.)|August 27, 2021
The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsMatthew J Page, Joanne E McKenzie, Patrick M Bossuyt, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|January 5, 2023
[The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsDeclaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas]Matthew J Page, Joanne E McKenzie, Patrick M Bossuyt, et al.
Systematic Reviews|March 30, 2021
The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsMatthew J Page, Joanne E McKenzie, Patrick M Bossuyt, et al.
BMJ (Clinical Research Ed.)|March 30, 2021
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviewsMatthew J Page, David Moher, Patrick M Bossuyt, et al.
Journal of Neurology|September 10, 2024
GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA)Sabrina Katzdobler, Georg Nübling, Martin Klietz, et al.
International Journal of Surgery (London, England)|April 1, 2021
The PRISMA 2020 statement: An updated guideline for reporting systematic reviewsMatthew J Page, Joanne E McKenzie, Patrick M Bossuyt, et al.
Nature Communications|October 9, 2025
Terahertz-field activation of polar skyronsHuaiyu Hugo Wang, Vladimir A Stoica, Cheng Dai, et al.
Pageof 88

Showing results (831-840 of 874) with videos related to

Sort By:
Pageof 88
Nature Communications|February 6, 2024
A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1Ling Hai, Dirk C Hoffmann, Robin J Wagener, et al.
Plos Medicine|March 29, 2021
The PRISMA 2020 statement: An updated guideline for reporting systematic reviewsMatthew J Page, Joanne E McKenzie, Patrick M Bossuyt, et al.
BMJ (Clinical Research Ed.)|March 30, 2021
The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsMatthew J Page, Joanne E McKenzie, Patrick M Bossuyt, et al.
Revista Espanola De Cardiologia (English Ed.)|August 27, 2021
The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsMatthew J Page, Joanne E McKenzie, Patrick M Bossuyt, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|January 5, 2023
[The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsDeclaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas]Matthew J Page, Joanne E McKenzie, Patrick M Bossuyt, et al.
Systematic Reviews|March 30, 2021
The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsMatthew J Page, Joanne E McKenzie, Patrick M Bossuyt, et al.
BMJ (Clinical Research Ed.)|March 30, 2021
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviewsMatthew J Page, David Moher, Patrick M Bossuyt, et al.
Journal of Neurology|September 10, 2024
GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA)Sabrina Katzdobler, Georg Nübling, Martin Klietz, et al.
International Journal of Surgery (London, England)|April 1, 2021
The PRISMA 2020 statement: An updated guideline for reporting systematic reviewsMatthew J Page, Joanne E McKenzie, Patrick M Bossuyt, et al.
Nature Communications|October 9, 2025
Terahertz-field activation of polar skyronsHuaiyu Hugo Wang, Vladimir A Stoica, Cheng Dai, et al.
Pageof 88